108 related articles for article (PubMed ID: 26846532)
21. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
[TBL] [Abstract][Full Text] [Related]
22. The role of iodinated contrast media in computed tomography structured Reporting and Data Systems (RADS): a narrative review.
Parillo M; van der Molen AJ; Asbach P; Elsholtz FHJ; Laghi A; Ronot M; Wu JS; Mallio CA; Quattrocchi CC
Quant Imaging Med Surg; 2023 Nov; 13(11):7621-7631. PubMed ID: 37969632
[TBL] [Abstract][Full Text] [Related]
23. Developing a lung nodule management protocol specifically for cardiac CT: Methodology in the DISCHARGE trial.
Haase R; Dodd JD; Kauczor HU; Kazerooni EA; Dewey M
Eur J Radiol Open; 2020; 7():100235. PubMed ID: 32637465
[TBL] [Abstract][Full Text] [Related]
24. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
25. [Lung Imaging Reporting and Data System (Lung-RADS) in Radiology: Strengths, Weaknesses and Improvement].
Jin GY
J Korean Soc Radiol; 2023 Jan; 84(1):34-50. PubMed ID: 36818696
[TBL] [Abstract][Full Text] [Related]
26. Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.
Friedlander LC; Roth SO; Gavenonis SC
Radiology; 2011 Nov; 261(2):421-7. PubMed ID: 21900618
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography.
Sone S; Nakayama T; Honda T; Tsushima K; Li F; Haniuda M; Takahashi Y; Suzuki T; Yamanda T; Kondo R; Hanaoka T; Takayama F; Kubo K; Fushimi H
Lung Cancer; 2007 Dec; 58(3):329-41. PubMed ID: 17675180
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese Population.
Meng Q; Ren P; Gao P; Dou X; Chen X; Guo L; Song Y
Cancer Manag Res; 2020; 12():189-198. PubMed ID: 32021435
[TBL] [Abstract][Full Text] [Related]
29. ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee.
Aiken AH; Rath TJ; Anzai Y; Branstetter BF; Hoang JK; Wiggins RH; Juliano AF; Glastonbury C; Phillips CD; Brown R; Hudgins PA
J Am Coll Radiol; 2018 Aug; 15(8):1097-1108. PubMed ID: 29983244
[TBL] [Abstract][Full Text] [Related]
30. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
31. A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans.
Alilou M; Prasanna P; Bera K; Gupta A; Rajiah P; Yang M; Jacono F; Velcheti V; Gilkeson R; Linden P; Madabhushi A
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205005
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer risk prediction to select smokers for screening CT--a model based on the Italian COSMOS trial.
Maisonneuve P; Bagnardi V; Bellomi M; Spaggiari L; Pelosi G; Rampinelli C; Bertolotti R; Rotmensz N; Field JK; Decensi A; Veronesi G
Cancer Prev Res (Phila); 2011 Nov; 4(11):1778-89. PubMed ID: 21813406
[TBL] [Abstract][Full Text] [Related]
33. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
34. Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
Muñoz-Largacha JA; Steiling KA; Kathuria H; Charlot M; Fitzgerald C; Suzuki K; Litle VR
J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2674-2681. PubMed ID: 29534906
[TBL] [Abstract][Full Text] [Related]
35. Rates of positive lung cancer screening examinations in academic versus community practice.
Henderson LM; Bacchus L; Benefield T; Huamani Velasquez R; Rivera MP
Transl Lung Cancer Res; 2020 Aug; 9(4):1528-1532. PubMed ID: 32953524
[TBL] [Abstract][Full Text] [Related]
36. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
[TBL] [Abstract][Full Text] [Related]
37. Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.
Kayat Bittencourt L; Litjens G; Hulsbergen-van de Kaa CA; Turkbey B; Gasparetto EL; Barentsz JO
Radiology; 2015 Aug; 276(2):479-89. PubMed ID: 25848900
[TBL] [Abstract][Full Text] [Related]
38. Automatic Lung-RADS™ classification with a natural language processing system.
Beyer SE; McKee BJ; Regis SM; McKee AB; Flacke S; El Saadawi G; Wald C
J Thorac Dis; 2017 Sep; 9(9):3114-3122. PubMed ID: 29221286
[TBL] [Abstract][Full Text] [Related]
39. Navigating the Pitfalls of Lung Cancer Screening: A Case Study on the Risks and Costs of Negative Screenings.
Shabpiray H; George J; Patel S; Khorsand Askari M
Cureus; 2024 May; 16(5):e59844. PubMed ID: 38854349
[TBL] [Abstract][Full Text] [Related]
40. Benign-appearing Incidental Adnexal Cysts at US, CT, and MRI: Putting the ACR, O-RADS, and SRU Guidelines All Together.
Wang PS; Schoeck OG; Horrow MM
Radiographics; 2022; 42(3):E105. PubMed ID: 35499977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
